Figures computed from official regulatory filings — .
Analysttarget 17.86 USD (+13%) · consensus 4.67/5 · 5 buy · 1 hold · 0 sell
Ownershipinsiders 6.79% · institutions 60.53% · short 7.1% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Aurinia Pharmaceuticals Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
43 buys82 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Robertson Stephen P. | Sell | $190.4K | SEC |
| Robertson Stephen P. | Sell | $355.9K | SEC |
| Bailey Jeffrey Allentrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Goetz Kathleentrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Nova Tina Susan | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Johnson Craig A | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| TANG KEVIN Ctrack record | OtherD (derivative) | $16.5K | SEC |
| TANG KEVIN Ctrack record | Buy | $3.1M | conv 19 | SEC |
| TANG KEVIN Ctrack record | Buy | $1.5K | conv 17 | SEC |
| TANG KEVIN Ctrack record | Buy | $4M | conv 26 | SEC |
| TANG KEVIN Ctrack record | Buy | $35.3K | conv 20 | SEC |
| TANG KEVIN Ctrack record | Buy | $5.2M | conv 27 | SEC |
| Robertson Stephen P. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cole Ryan | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cole Ryan | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hearne Michael Strack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hearne Michael Strack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Keenan Greg | Other | $115.5K | SEC |
| TANG KEVIN Ctrack record | Buy | $4.2M | conv 34 | SEC |
| Greenleaf Peter | Other | $1.4M | SEC |
| Robertson Stephen P. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Greenleaf Peter | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| TANG KEVIN Ctrack record | Buy | $1.2M | conv 20 | SEC |
| TANG KEVIN Ctrack record | Buy | $2.6M | conv 22 | SEC |
| Miller Joseph M | Other | $533K | SEC |